VANCOUVER, Feb. 4 /CNW/ - Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Corporation") is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions. A notice of allowance from the United States Patent and Trademark Office is a written notification that a patent application has cleared internal review and is nearing issuance.
Canola offers a unique amino acid profile, rich in sulfur-containing amino acids, an abundant source of protein, and two distinct protein fractions: napin and cruciferin. Napin is an albumin storage protein and cruciferin is a globulin storage protein. Burcon's proprietary process allows for the separation of these two distinct fractions resulting in a cruciferin-rich canola protein isolate Puratein(R) and a napin-rich canola protein isolate Supertein(TM). In addition to their inherent nutritional value, these protein ingredients possess distinct characteristic functional properties. Puratein(R) has emulsifying, gelling, and binding properties that make it suitable for use in food applications including sauces, dressings, meat substitutes, baked goods and bars. The functional properties of Supertein(TM) include excellent solubility, the ability to form transparent solutions, foaming and nutrition. Applications for Supertein(TM) include beverages, confectionery, aerated desserts, and protein bars, among many others.
"The two naturally occurring proteins in canola have highly distinct functional and nutritional characteristics, similar to the way that the two proteins in egg, egg-yolk and egg-white, have distinct characteristics ," said Johann F. Tergesen, President and Chief Operating Officer, adding, "Our patented processes for the production of Puratein(R) and Supertein(TM) canola protein isolates create two distinct protein ingredients with separate nutritional and functional profiles allowing for their use in specific food and beverage applications."
To-date, Burcon's patent portfolio consists of 115 issued patents in various countries, including 12 issued U.S. patents, and in excess of 200 additional pending patent applications, 68 of which are U.S. patent applications. Six of Burcon's 68 U.S. patent applications have now been allowed, including the patent allowance which is the subject of this news release, and will be issued as granted U.S. patents in the near future.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing Puratein(R) and Supertein(TM) canola protein isolates with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 115 issued patents in various countries, including 12 issued U.S. patents, and in excess of 200 additional pending patent applications, 68 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
Burcon NutraScience Corporation is a publicly listed on the Toronto Stock Exchange under the symbol "BU". For more information on Burcon, visit www.burcon.ca.
This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, the Corporation's, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal", "intend", "believes", "potential", "expected", "anticipates", "will be", and similar expressions, generally identify forward looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.
SOURCE Burcon NutraScience Corporation
For further information: For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free, firstname.lastname@example.org, www.burcon.ca; AXINO AG, Wolfgang Seybold, Investor Relations Europe, AXINO AG, Königstrasse 26, 70173, Stuttgart, Germany, Tel. +49-711-25 35 92-40, Fax +49-711-25 35 92-55, email@example.com, www.burcon.net